Melius Research downgraded Ingersoll-Rand (IR) to Hold from Buy with a $93 price target While Melius continues to see Ingersoll-Rand as a core holding, the firm doesn’t have a compelling case for outperformance, the analyst tells investors in a research note. This quarter could see some margin relief from tariffs, but the resolution of tariff uncertainty continues to be delayed, while the Big Beautiful Bill has put a lot of uncertainty into clean tech and healthcare end markets, the firm says.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IR:
- Ingersoll-Rand downgraded to Hold from Buy at Melius Research
- Ingersoll-Rand price target raised to $92 from $85 at Barclays
- Ingersoll-Rand acquires Termomeccanica Industrial Compressors, terms undisclosed
- Ingersoll-Rand price target raised to $95 from $86 at Wells Fargo
- Ingersoll Rand Positioned for Long-Term Growth: Buy Rating Affirmed by Andrew Kaplowitz